Literature DB >> 3876092

Effect of chronic smoking on fibrinolysis.

R A Allen, C Kluft, E J Brommer.   

Abstract

The aim of the study was to investigate the long-term chronic effects of smoking on the fibrinolytic enzyme system by comparing two groups of healthy male volunteers (aged 30 to 40 years). One group consisted of 15 habitual smokers who consumed 20 or more cigarettes a day; the other consisted of 15 nonsmokers. Fibrinolysis was studied at rest (baseline) and after infusion of 1-desamino-8-D-arginine vasopressin (DDAVP; 0.4 micrograms/kg body weight). Smokers had significantly lower baseline blood fibrinolytic activity as determined by the overall assays: dilute blood clot lysis (p less than or equal to 0.05) and euglobulin-fibrin plate assay (p less than or equal to 0.05). Further analysis showed that these low activities could be attributed to a lower baseline level of extrinsic tissue-type plasminogen activator (t-PA) activity (p less than or equal to 0.05) in the smokers. There were no significant differences between the groups in various fibrinolytic inhibitors or in the intrinsic fibrinolytic activation pathways. The increased levels of t-PA activity and factor VIII R:Ag in response to DDAVP were also reduced in the smokers (p less than or equal to 0.01). The relative increase (ratio of post-DDAVP activity/baseline activity) for these parameters was not significantly different for the two groups. Smokers also had significantly higher levels of the acute phase reactants, alpha 1-antitrypsin (p less than or equal to 0.02) and plasminogen (p less than or equal to 0.02) and C-reactive protein (p less than or equal to 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876092     DOI: 10.1161/01.atv.5.5.443

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  9 in total

1.  The smoker's paradox and the real risk of smoking.

Authors:  Friedebert Kunz; Christoph Pechlaner; Helmut Hörtnagl; Rudolf Pfister
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  The biology behind the atherothrombotic effects of cigarette smoke.

Authors:  Adam Csordas; David Bernhard
Journal:  Nat Rev Cardiol       Date:  2013-02-05       Impact factor: 32.419

3.  Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction.

Authors:  Andrew P DeFilippis; Ilya Chernyavskiy; Alok R Amraotkar; Patrick J Trainor; Shalin Kothari; Imtiaz Ismail; Charles W Hargis; Frederick K Korley; Gregor Leibundgut; Sotirios Tsimikas; Shesh N Rai; Aruni Bhatnagar
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

4.  Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty.

Authors:  A G Violaris; A Thury; E Regar; R Melkert; P W Serruys
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

Review 5.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

6.  Effects of cigarette smoking or ingestion of nicotine on platelet 5-hydroxytryptamine (5-HT) levels in smokers and non-smokers.

Authors:  K Racké; H Schwörer; G Simson
Journal:  Clin Investig       Date:  1992 Mar-Apr

7.  Effect of chronic nicotine delivery on the proliferation rate of endothelial and smooth muscle cells in experimentally induced vascular wall plaques.

Authors:  T Strohschneider; M Oberhoff; H Hanke; A Hannekum; K R Karsch
Journal:  Clin Investig       Date:  1994-11

8.  [Persistent changes in tissue-type plasminogen activator and plasminogen activator inhibitor fibrinolytic parameters in patients following juvenile ischemic cerebral infarct].

Authors:  C Baumgartner; K Huber; F Holzner; K Zeiler; E Auff; B R Binder
Journal:  Klin Wochenschr       Date:  1988-11-15

9.  Prothrombotic abnormalities in inflammatory bowel disease.

Authors:  M G Conlan; W D Haire; D A Burnett
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.